메뉴 건너뛰기




Volumn 75, Issue 7, 2004, Pages 951-957

Botulinum toxin in clinical practice

Author keywords

[No Author keywords available]

Indexed keywords

BACLOFEN; BOTULINUM TOXIN; BOTULINUM TOXIN A; BOTULINUM TOXIN B; MUSCLE RELAXANT AGENT; PHENOL; TIZANIDINE;

EID: 3042747490     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.2003.034702     Document Type: Review
Times cited : (337)

References (100)
  • 1
    • 0033544305 scopus 로고    scopus 로고
    • Historical aspects of botulinum toxin. Justinus Kerner (1786-1862) and the "sausage" poison
    • Erbguth FJ, Naumann M. Historical aspects of botulinum toxin. Justinus Kerner (1786-1862) and the "sausage" poison. Neurology 1999;53:1850-3.
    • (1999) Neurology , vol.53 , pp. 1850-1853
    • Erbguth, F.J.1    Naumann, M.2
  • 2
    • 0032817460 scopus 로고    scopus 로고
    • On the discovery of Clostridium botulinum
    • Devriese PP. On the discovery of Clostridium botulinum. J History Neurosci 1999;8:43-50.
    • (1999) J History Neurosci , vol.8 , pp. 43-50
    • Devriese, P.P.1
  • 3
    • 0035961566 scopus 로고    scopus 로고
    • Botulinum toxin as a biological weapon. Medical and public health management
    • Arnon SS, Schecter R, Inqlesby TV, et al. Botulinum toxin as a biological weapon. Medical and public health management. JAMA 2001;285:1059-70.
    • (2001) JAMA , vol.285 , pp. 1059-1070
    • Arnon, S.S.1    Schecter, R.2    Inqlesby, T.V.3
  • 4
    • 0019761968 scopus 로고
    • Botulinum toxin injection of eye muscles to correct strabismus
    • Scott AB. Botulinum toxin injection of eye muscles to correct strabismus. Trans Am Ophthalmol Soc 1981;79:734-9.
    • (1981) Trans Am Ophthalmol Soc , vol.79 , pp. 734-739
    • Scott, A.B.1
  • 5
    • 0035411166 scopus 로고    scopus 로고
    • Focal dystonia: The role of botulinum toxin
    • Tintner R, Jankovic J. Focal dystonia: the role of botulinum toxin. Curr Neurol Neurosci 2001;1:337-45.
    • (2001) Curr Neurol Neurosci , vol.1 , pp. 337-345
    • Tintner, R.1    Jankovic, J.2
  • 7
    • 2942520007 scopus 로고    scopus 로고
    • Molecular targets of botulinum toxin at the mammalian neuromuscular junction
    • Whelchel DD, Brehmer TM, Brooks PM, et al. Molecular targets of botulinum toxin at the mammalian neuromuscular junction. Mov Disord 2004;19(Suppl 8):S7-S16.
    • (2004) Mov Disord , vol.19 , Issue.8 SUPPL.
    • Whelchel, D.D.1    Brehmer, T.M.2    Brooks, P.M.3
  • 8
    • 3042852947 scopus 로고    scopus 로고
    • Different types of botulinum toxin in humans
    • Eleopra R, Tugnoli V, Quatrale R, et al. Different types of botulinum toxin in humans. Mov Disord 2004;19(Suppl 8):S53-9.
    • (2004) Mov Disord , vol.19 , Issue.8 SUPPL.
    • Eleopra, R.1    Tugnoli, V.2    Quatrale, R.3
  • 9
    • 3042774054 scopus 로고    scopus 로고
    • Basic immunological aspects of botulinum toxin therapy
    • Atassi MZ. Basic immunological aspects of botulinum toxin therapy. Mov Dosord 2004;19(Suppl 8):S68-84.
    • (2004) Mov Dosord , vol.19 , Issue.8 SUPPL.
    • Atassi, M.Z.1
  • 10
    • 0011103440 scopus 로고    scopus 로고
    • Structural view of botulinum neurotoxin in numerous functional states
    • Brin MF, Hallett M, Jankovic J, eds. Philadelphia: Lippincott Williams & Wilkins
    • Hanson MA, Stevens RC. Structural view of botulinum neurotoxin in numerous functional states. In: Brin MF, Hallett M, Jankovic J, eds. Scientific and therapeutic aspects of botulinum taxin. Philadelphia: Lippincott Williams & Wilkins, 2002:11-28.
    • (2002) Scientific and Therapeutic Aspects of Botulinum Taxin , pp. 11-28
    • Hanson, M.A.1    Stevens, R.C.2
  • 11
    • 0035030442 scopus 로고    scopus 로고
    • Molecular mechanisms of neurotransmitter release
    • Fon EA, Edwards RH. Molecular mechanisms of neurotransmitter release. Muscle Nerve 2001;24:581-601.
    • (2001) Muscle Nerve , vol.24 , pp. 581-601
    • Fon, E.A.1    Edwards, R.H.2
  • 12
    • 0034598654 scopus 로고    scopus 로고
    • Persistence of botulinum neurotoxin A demonstrated by sequential administration of serotypes A and E in rat EDL muscle
    • Adler M, Keller JE, Sheridan RE, et al. Persistence of botulinum neurotoxin A demonstrated by sequential administration of serotypes A and E in rat EDL muscle. Toxicon 2001;39:233-43.
    • (2001) Toxicon , vol.39 , pp. 233-243
    • Adler, M.1    Keller, J.E.2    Sheridan, R.E.3
  • 14
    • 0033055065 scopus 로고    scopus 로고
    • Functional repair of motor endplates after botulinum neurotoxin A poisoning: Bi-phasic switch of synaptic activity between nerve sprouts and their parent terminals
    • de Paiva A, Meunier FA, Molgó J, et al. Functional repair of motor endplates after botulinum neurotoxin A poisoning: Bi-phasic switch of synaptic activity between nerve sprouts and their parent terminals. Proc Natl Acad Sci USA 1999;96:3200-5.
    • (1999) Proc Natl Acad Sci USA , vol.96 , pp. 3200-3205
    • De Paiva, A.1    Meunier, F.A.2    Molgó, J.3
  • 15
    • 0037428398 scopus 로고    scopus 로고
    • Evaluation of the therapeutic usefulness of botulinum neurotoxin B, C1, E, and F compared with the long lasting type A. Basis for distinct durations of inhibition of exocytosis in central neurons
    • Foran PG, Mohammed N, Lisk GO, et al. Evaluation of the therapeutic usefulness of botulinum neurotoxin B, C1, E, and F compared with the long lasting type A. Basis for distinct durations of inhibition of exocytosis in central neurons. J Biol Chem 2003;278:1363-71.
    • (2003) J Biol Chem , vol.278 , pp. 1363-1371
    • Foran, P.G.1    Mohammed, N.2    Lisk, G.O.3
  • 16
    • 0032892281 scopus 로고    scopus 로고
    • Comparison of mouse bioassay and immunaprecipitatian assay for botulinum toxin antibodies
    • Hanna PA, Jankovic J, Vincent A. Comparison of mouse bioassay and immunaprecipitatian assay for botulinum toxin antibodies. J Neurol Neurosurg Psychiatry 1999;66:612-16.
    • (1999) J Neurol Neurosurg Psychiatry , vol.66 , pp. 612-616
    • Hanna, P.A.1    Jankovic, J.2    Vincent, A.3
  • 17
    • 0036869216 scopus 로고    scopus 로고
    • Long-term efficacy of botulinum toxin A in treatment of various movement disorders over a 10-year period
    • Hsiung G-YR, Das SK, Ranawaya R, et al. Long-term efficacy of botulinum toxin A in treatment of various movement disorders over a 10-year period. Mov Disord 2002;17:1288-93.
    • (2002) Mov Disord , vol.17 , pp. 1288-1293
    • Hsiung, G.-Y.R.1    Das, S.K.2    Ranawaya, R.3
  • 18
    • 1842856251 scopus 로고    scopus 로고
    • Cross reaction of tetanus and botulinum neurotoxins A and B and the boosting effect of botulinum neurotoxins A and B on a primary anti-tetanus antibody response
    • Dolimbek BZ, Jankovic J, Atassi MZ. Cross reaction of tetanus and botulinum neurotoxins A and B and the boosting effect of botulinum neurotoxins A and B on a primary anti-tetanus antibody response. Immunol Invest 2002;31:247-62.
    • (2002) Immunol Invest , vol.31 , pp. 247-262
    • Dolimbek, B.Z.1    Jankovic, J.2    Atassi, M.Z.3
  • 19
    • 0037426445 scopus 로고    scopus 로고
    • Comparison of efficacy and immunogenicity of original versus current botulinum toxin in cervical dystonia
    • Jankovic J, Vuong KD, Ahsan J. Comparison of efficacy and immunogenicity of original versus current botulinum toxin in cervical dystonia. Neurology 2003;60:1186-8.
    • (2003) Neurology , vol.60 , pp. 1186-1188
    • Jankovic, J.1    Vuong, K.D.2    Ahsan, J.3
  • 20
    • 0032951652 scopus 로고    scopus 로고
    • Long-term treatment of cervical dystonia with botulinum toxin A: Efficacy, safety, and antibody frequency
    • German Dystonia Study Group
    • Kessler KR, Skutta M, Benecke R. Long-term treatment of cervical dystonia with botulinum toxin A: efficacy, safety, and antibody frequency. German Dystonia Study Group. J Neurol 1999;246:265-74.
    • (1999) J Neurol , vol.246 , pp. 265-274
    • Kessler, K.R.1    Skutta, M.2    Benecke, R.3
  • 21
    • 0034783113 scopus 로고    scopus 로고
    • Needle EMG guidance is rarely required
    • Jankovic J. Needle EMG guidance is rarely required. Muscle Nerve 2001;24:1568-70.
    • (2001) Muscle Nerve , vol.24 , pp. 1568-1570
    • Jankovic, J.1
  • 22
    • 3042855218 scopus 로고    scopus 로고
    • Basic and therapeutic aspects of neurotonins
    • Bigalke H, Dressier D, Jankovic J. Basic and therapeutic aspects of neurotonins. Mov Disord 2004; 19(Suppl 8):S1.
    • (2004) Mov Disord , vol.19 , Issue.8 SUPPL.
    • Bigalke, H.1    Dressier, D.2    Jankovic, J.3
  • 23
    • 0142103736 scopus 로고    scopus 로고
    • Dystonia: Medical therapy and botulinum toxin
    • Jankovic J. Dystonia: medical therapy and botulinum toxin. Adv Neurol 2004;94:275-86.
    • (2004) Adv Neurol , vol.94 , pp. 275-286
    • Jankovic, J.1
  • 24
    • 0023142826 scopus 로고
    • Botulinum A toxin for cranial-cervical dystonia: A double-blind, placebo-controlled study
    • Jankovic J, Orman J. Botulinum A toxin for cranial-cervical dystonia: a double-blind, placebo-controlled study. Neurology 1987;37:616-23.
    • (1987) Neurology , vol.37 , pp. 616-623
    • Jankovic, J.1    Orman, J.2
  • 25
    • 0025082911 scopus 로고
    • Botulinum toxin treatment of cranial-cervical dystonia, spasmodic dysphonia, other focal dystonias and hemifacial spasm
    • Jankovic J, Schwartz K, Donovan DT. Botulinum toxin treatment of cranial-cervical dystonia, spasmodic dysphonia, other focal dystonias and hemifacial spasm. J Neurol Neurosurg Psychiatry 1990;53:633-9.
    • (1990) J Neurol Neurosurg Psychiatry , vol.53 , pp. 633-639
    • Jankovic, J.1    Schwartz, K.2    Donovan, D.T.3
  • 26
    • 0034132347 scopus 로고    scopus 로고
    • Treating severe bruxism with botulinum toxin
    • Tan E-K, Jankovic J. Treating severe bruxism with botulinum toxin. J Am Dent Assoc 2000;131:211-16.
    • (2000) J Am Dent Assoc , vol.131 , pp. 211-216
    • Tan, E.-K.1    Jankovic, J.2
  • 27
    • 0031761314 scopus 로고    scopus 로고
    • Hemifacial spasm: Clinical correlates and treatments
    • Wang A, Jankovic J. Hemifacial spasm: clinical correlates and treatments. Muscle Nerve 1998;21:1740-7.
    • (1998) Muscle Nerve , vol.21 , pp. 1740-1747
    • Wang, A.1    Jankovic, J.2
  • 28
    • 0036191227 scopus 로고    scopus 로고
    • Botulinum toxin a treatment for primary hemifacial spasm: A 10-year multicenter study
    • Defazio G, Abbruzzese G, Girlanda P, et al. Botulinum toxin a treatment for primary hemifacial spasm: a 10-year multicenter study. Arch Neurol 2002;59:418-20.
    • (2002) Arch Neurol , vol.59 , pp. 418-420
    • Defazio, G.1    Abbruzzese, G.2    Girlanda, P.3
  • 29
    • 3042818315 scopus 로고    scopus 로고
    • Treatment of cervical dystonia with botulinum toxin
    • Jankovic J. Treatment of cervical dystonia with botulinum toxin. Mov Disord 2004;19(Suppl 8):S109-15.
    • (2004) Mov Disord , vol.19 , Issue.8 SUPPL.
    • Jankovic, J.1
  • 30
    • 0030670813 scopus 로고    scopus 로고
    • Symptomatic and functional outcome of surgical treatment of cervical dystonia
    • Krauss JK, Toops EG, Jankovic J, et al. Symptomatic and functional outcome of surgical treatment of cervical dystonia. J Neurol Neurosurg Psychiatry 1997;63:642-8.
    • (1997) J Neurol Neurosurg Psychiatry , vol.63 , pp. 642-648
    • Krauss, J.K.1    Toops, E.G.2    Jankovic, J.3
  • 31
    • 0032718516 scopus 로고    scopus 로고
    • Safety and efficacy of Neurobloc (botulinum toxin type B) in type A-responsive cervical dystonia
    • Brashear A, Lew MF, Dykstra DD, et al. Safety and efficacy of Neurobloc (botulinum toxin type B) in type A-responsive cervical dystonia. Neurology 1999;53:1439-46.
    • (1999) Neurology , vol.53 , pp. 1439-1446
    • Brashear, A.1    Lew, M.F.2    Dykstra, D.D.3
  • 32
    • 0032716402 scopus 로고    scopus 로고
    • Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-resistant cervical dystonia
    • Brin MF, Lew MF, Adler CH, et al. Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-resistant cervical dystonia. Neurology 1999;53:1431-8.
    • (1999) Neurology , vol.53 , pp. 1431-1438
    • Brin, M.F.1    Lew, M.F.2    Adler, C.H.3
  • 33
    • 0031775483 scopus 로고    scopus 로고
    • Botulinum toxin type F for treatment of dystonia: Long-term experience
    • Chen R, Karp BI, Hallett M. Botulinum toxin type F for treatment of dystonia: long-term experience. Neurology 1998;51:1494-6.
    • (1998) Neurology , vol.51 , pp. 1494-1496
    • Chen, R.1    Karp, B.I.2    Hallett, M.3
  • 34
    • 2442579318 scopus 로고    scopus 로고
    • Botulinum toxin type A injections for the management of the hyperfunctional larynx
    • Brin MF, Hallett M, Jankovic J, eds. Philadelphia: Lippincott Williams & Wilkins
    • Blitzer A, Zalvan C, Gonzalez-Yanez O, et al. Botulinum toxin type A injections for the management of the hyperfunctional larynx. In: Brin MF, Hallett M, Jankovic J, eds. Scientific and therapeutic aspects of botulinum toxin. Philadelphia: Lippincott Williams & Wilkins, 2002:207-16.
    • (2002) Scientific and Therapeutic Aspects of Botulinum Toxin , pp. 207-216
    • Blitzer, A.1    Zalvan, C.2    Gonzalez-Yanez, O.3
  • 35
    • 0033757911 scopus 로고    scopus 로고
    • Outcomes assessment following treatment of spasmodic dysphonia with botulinum toxin
    • Courey MS, Garrett CG, Billante CR, et al. Outcomes assessment following treatment of spasmodic dysphonia with botulinum toxin. Ann Otol Rhinol Laryngol 2000;109:819-22.
    • (2000) Ann Otol Rhinol Laryngol , vol.109 , pp. 819-822
    • Courey, M.S.1    Garrett, C.G.2    Billante, C.R.3
  • 36
    • 0028109629 scopus 로고
    • Laryngeal botulinum taxin injections for disabling stuttering in adults
    • Brin MF, Stewart C, Blitzer A, et al. Laryngeal botulinum taxin injections for disabling stuttering in adults. Neurology 1994;44:2262-6.
    • (1994) Neurology , vol.44 , pp. 2262-2266
    • Brin, M.F.1    Stewart, C.2    Blitzer, A.3
  • 37
    • 0033890804 scopus 로고    scopus 로고
    • Botulinum toxin for essential tremor of the voice with multiple anatomical sites of tremor: A crossover design study of unilateral versus bilateral injection
    • Warrick P, Dromey C, Irish JC, et al. Botulinum toxin for essential tremor of the voice with multiple anatomical sites of tremor: a crossover design study of unilateral versus bilateral injection. Laryngoscope 2000;110:1366-74.
    • (2000) Laryngoscope , vol.110 , pp. 1366-1374
    • Warrick, P.1    Dromey, C.2    Irish, J.C.3
  • 38
    • 0026059861 scopus 로고
    • Writer's cramp: Treatment with botulinum toxin injections
    • Rivest J, Lees AJ, Marsden CD. Writer's cramp: Treatment with botulinum toxin injections. Mov Disord 1990;6:55-9.
    • (1990) Mov Disord , vol.6 , pp. 55-59
    • Rivest, J.1    Lees, A.J.2    Marsden, C.D.3
  • 39
    • 0037066095 scopus 로고    scopus 로고
    • Accuracy of muscle localization without EMG: Implications of limb dystonia
    • Molloy FM, Shill HA, Kaelin-Lang A, et al. Accuracy of muscle localization without EMG: implications of limb dystonia. Neurology 2002;58:805-7.
    • (2002) Neurology , vol.58 , pp. 805-807
    • Molloy, F.M.1    Shill, H.A.2    Kaelin-Lang, A.3
  • 40
    • 0031919375 scopus 로고    scopus 로고
    • The corticomotor representation of upper limb muscles in writer's cramp and changes following botulinum toxin injections
    • Byrnes ML, Thickbroom GW, Wilson SA, et al. The corticomotor representation of upper limb muscles in writer's cramp and changes following botulinum toxin injections. Brain 1998;121:977-88.
    • (1998) Brain , vol.121 , pp. 977-988
    • Byrnes, M.L.1    Thickbroom, G.W.2    Wilson, S.A.3
  • 41
    • 0035470378 scopus 로고    scopus 로고
    • Treatment of dystonic clenched fist with botulinum toxin
    • Cordivari C, Misra P, Catania S, et al. Treatment of dystonic clenched fist with botulinum toxin. Mov Disord 2001;16:907-13.
    • (2001) Mov Disord , vol.16 , pp. 907-913
    • Cordivari, C.1    Misra, P.2    Catania, S.3
  • 42
    • 0029873564 scopus 로고    scopus 로고
    • A randomized, double-blind, placebo-controlled study to evaluate botulinum toxin type A in essential hand tremor
    • Jankovic J, Schwartz K, Clemence W, et al. A randomized, double-blind, placebo-controlled study to evaluate botulinum toxin type A in essential hand tremor. Mov Disord 1996;11:250-6.
    • (1996) Mov Disord , vol.11 , pp. 250-256
    • Jankovic, J.1    Schwartz, K.2    Clemence, W.3
  • 43
    • 0035849562 scopus 로고    scopus 로고
    • A randomized, double masked, controlled trial of botulinum toxin type A in essential hand tremor
    • Brin MF, Lyons KE, Doucette J, et al. A randomized, double masked, controlled trial of botulinum toxin type A in essential hand tremor. Neurology 2001;56:1523-8.
    • (2001) Neurology , vol.56 , pp. 1523-1528
    • Brin, M.F.1    Lyons, K.E.2    Doucette, J.3
  • 44
    • 0030884685 scopus 로고    scopus 로고
    • Quantitative assessment of botulinum toxin treatment in 43 patients with head tremor
    • Wissel J, Masuhr F, Schelosky L, et al. Quantitative assessment of botulinum toxin treatment in 43 patients with head tremor. Mov Disord 1997;12:722-6.
    • (1997) Mov Disord , vol.12 , pp. 722-726
    • Wissel, J.1    Masuhr, F.2    Schelosky, L.3
  • 45
    • 0035909663 scopus 로고    scopus 로고
    • Tourette's syndrome
    • Jankovic J. Tourette's syndrome. N Engl J Med 2001;345:1184-92.
    • (2001) N Engl J Med , vol.345 , pp. 1184-1192
    • Jankovic, J.1
  • 46
    • 0033876785 scopus 로고    scopus 로고
    • Botulinum toxin in the treatment of tics
    • Kwak CH, Hanna PA, Jankovic J. Botulinum toxin in the treatment of tics. Arch Neurol 2000;57:1190-3.
    • (2000) Arch Neurol , vol.57 , pp. 1190-1193
    • Kwak, C.H.1    Hanna, P.A.2    Jankovic, J.3
  • 47
    • 0035852961 scopus 로고    scopus 로고
    • Botulinum toxin for simple motor tics: A randomized, double-blind, controlled clinical trial
    • Marras C, Andrews D, Sime EA, et al. Botulinum toxin for simple motor tics: a randomized, double-blind, controlled clinical trial. Neurology 2001;56:605-10.
    • (2001) Neurology , vol.56 , pp. 605-610
    • Marras, C.1    Andrews, D.2    Sime, E.A.3
  • 48
    • 17344389543 scopus 로고    scopus 로고
    • Recommendations for the use of botulinum toxin type A in the management of cerebral palsy
    • Graham HK, Aoki KR, Autti-Ramo I, et al. Recommendations for the use of botulinum toxin type A in the management of cerebral palsy. Gait Posture 2000;11:67-79.
    • (2000) Gait Posture , vol.11 , pp. 67-79
    • Graham, H.K.1    Aoki, K.R.2    Autti-Ramo, I.3
  • 49
    • 0033926243 scopus 로고    scopus 로고
    • Impact of botulinum toxin type A on disability and carer burden due to arm spasticity after stroke: A randomized double blind placebo controlled trial
    • Bhakta BB, Cozens JA, Chamberlain A, et al. Impact of botulinum toxin type A on disability and carer burden due to arm spasticity after stroke: a randomized double blind placebo controlled trial. J Neurol Neurosurg Psychiatry 2000;69:217-21.
    • (2000) J Neurol Neurosurg Psychiatry , vol.69 , pp. 217-221
    • Bhakta, B.B.1    Cozens, J.A.2    Chamberlain, A.3
  • 50
    • 18344414156 scopus 로고    scopus 로고
    • Management of upper limb dysfunction in children with cerebral palsy: A systematic review
    • Boyd RN, Morris ME, Graham HK. Management of upper limb dysfunction in children with cerebral palsy: a systematic review. Eur J Neurol 2001;8(suppl 5):150-66.
    • (2001) Eur J Neurol , vol.8 , Issue.5 SUPPL. , pp. 150-166
    • Boyd, R.N.1    Morris, M.E.2    Graham, H.K.3
  • 51
    • 3042772864 scopus 로고    scopus 로고
    • The use af botulinum taxin in juvenile cerebral palsy
    • Brin MF, Hallett M, Jankavic J, eds. Philadelphia: Lippincott Williams & Wilkins
    • Delgado MR. The use af botulinum taxin in juvenile cerebral palsy. In: Brin MF, Hallett M, Jankavic J, eds. Scientific and therapeutic aspects of botulinum toxin. Philadelphia: Lippincott Williams & Wilkins, 2002:217-22.
    • (2002) Scientific and Therapeutic Aspects of Botulinum Toxin , pp. 217-222
    • Delgado, M.R.1
  • 52
    • 0036773435 scopus 로고    scopus 로고
    • Botulinum toxin treatment of spasticity in diplegic cerebral palsy: A randomized, double-blind, placebo-controlled, dose-ranging study
    • Boker R, Jasinski M, Maciag-Tymecka I, et al. Botulinum toxin treatment of spasticity in diplegic cerebral palsy: a randomized, double-blind, placebo-controlled, dose-ranging study. Dev Med Child Neurol 2002;44:666-75.
    • (2002) Dev Med Child Neurol , vol.44 , pp. 666-675
    • Boker, R.1    Jasinski, M.2    Maciag-Tymecka, I.3
  • 53
    • 0037043682 scopus 로고    scopus 로고
    • Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after a stroke
    • Brasheor A, Gordon MF, Elovic E, et al. Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after a stroke. N Engl J Med 2002;347:395-400.
    • (2002) N Engl J Med , vol.347 , pp. 395-400
    • Brasheor, A.1    Gordon, M.F.2    Elovic, E.3
  • 54
    • 0344882590 scopus 로고    scopus 로고
    • Comparison of phenol block and botulinus toxin type A in the treatment of spastic foot after stroke: A randomized, double-blind trial
    • Kirazli Y, Yagiz On A, Kismali B, et al. Comparison of phenol block and botulinus toxin type A in the treatment of spastic foot after stroke: a randomized, double-blind trial. Am J Phys Med Rehabil 1998;77:510-15.
    • (1998) Am J Phys Med Rehabil , vol.77 , pp. 510-515
    • Kirazli, Y.1    Yagiz On, A.2    Kismali, B.3
  • 55
    • 0034067174 scopus 로고    scopus 로고
    • Botulinum toxin (Dysport ®) treatment of hip adductor in multiple sclerosis: A prospective, randomised, double blind, placebo controlled, dose ranging study
    • Hyman N, Barnes M, Bhakta B, et al. Botulinum toxin (Dysport ®) treatment of hip adductor in multiple sclerosis: a prospective, randomised, double blind, placebo controlled, dose ranging study. J Neurol Neurosurg Psychiatry 2000;68:707-12.
    • (2000) J Neurol Neurosurg Psychiatry , vol.68 , pp. 707-712
    • Hyman, N.1    Barnes, M.2    Bhakta, B.3
  • 56
    • 0028962535 scopus 로고
    • Botulinum toxin A for spasticity, muscle spasms, and rigidity
    • Grazko M, Polo KB, Jabbori B. Botulinum toxin A for spasticity, muscle spasms, and rigidity. Neurology 1995;45:712-17.
    • (1995) Neurology , vol.45 , pp. 712-717
    • Grazko, M.1    Polo, K.B.2    Jabbori, B.3
  • 57
    • 0027219703 scopus 로고
    • Significant improvement of stiff-person syndrome after paraspinal injection of botulinum toxin A
    • Dovis D, Jabbari B. Significant improvement of stiff-person syndrome after paraspinal injection of botulinum toxin A. Mov Disord 1993;8:371-3.
    • (1993) Mov Disord , vol.8 , pp. 371-373
    • Dovis, D.1    Jabbari, B.2
  • 58
    • 9544250392 scopus 로고    scopus 로고
    • A randomised, double-blind, placebo controlled trial of botulinum toxin in the treatment of spastic foot in hemiparetic patients
    • Burbaud P, Wiart L, Dubos JL, et al. A randomised, double-blind, placebo controlled trial of botulinum toxin in the treatment of spastic foot in hemiparetic patients. J Neurol Neurosurg Psychiatry 1996;61:265-9.
    • (1996) J Neurol Neurosurg Psychiatry , vol.61 , pp. 265-269
    • Burbaud, P.1    Wiart, L.2    Dubos, J.L.3
  • 59
    • 0035933051 scopus 로고    scopus 로고
    • Botulinum toxin A and chronic low back pain: A randomized, double-blind study
    • Foster L, Clapp L, Erickson M, et al. Botulinum toxin A and chronic low back pain: a randomized, double-blind study. Neurology 2001;56:1290-3.
    • (2001) Neurology , vol.56 , pp. 1290-1293
    • Foster, L.1    Clapp, L.2    Erickson, M.3
  • 60
    • 0036782213 scopus 로고    scopus 로고
    • Botulinum toxin therapy for myofascial pain disorders
    • Lang AM. Botulinum toxin therapy for myofascial pain disorders. Curr Pain Headache Rep 2002;6:355-60.
    • (2002) Curr Pain Headache Rep , vol.6 , pp. 355-360
    • Lang, A.M.1
  • 61
    • 0036884482 scopus 로고    scopus 로고
    • Botulinum toxin for the treatment of musculoskeletal pain and spasm
    • Sheeon G. Botulinum toxin for the treatment of musculoskeletal pain and spasm. Curr Pain Headache Rep 2002;6:460-9.
    • (2002) Curr Pain Headache Rep , vol.6 , pp. 460-469
    • Sheeon, G.1
  • 62
    • 1542329006 scopus 로고    scopus 로고
    • Botulinum toxin and other new approaches to migraine therapy
    • Ashkenazi A, Silberstein SD. Botulinum toxin and other new approaches to migraine therapy. Annu Rev Med 2004;55:505-18.
    • (2004) Annu Rev Med , vol.55 , pp. 505-518
    • Ashkenazi, A.1    Silberstein, S.D.2
  • 63
    • 0034883733 scopus 로고    scopus 로고
    • Effect of botulinum toxin A injections in the treatment of chronic tension-type headache: A double-blind, placebo-controlled trial
    • Schmitt WJ, Slowey E, Fravi N, et al. Effect of botulinum toxin A injections in the treatment of chronic tension-type headache: a double-blind, placebo-controlled trial. Headache 2001;41:658-64.
    • (2001) Headache , vol.41 , pp. 658-664
    • Schmitt, W.J.1    Slowey, E.2    Fravi, N.3
  • 64
    • 0036834143 scopus 로고    scopus 로고
    • Treatment of headache with botulinum toxin A - A review according to evidence-based medicine criteria
    • Evens S, Rahmann A, Vollmer-Haase J, et al. Treatment of headache with botulinum toxin A - a review according to evidence-based medicine criteria. Cephalalgia 2002;22:699-710.
    • (2002) Cephalalgia , vol.22 , pp. 699-710
    • Evens, S.1    Rahmann, A.2    Vollmer-Haase, J.3
  • 65
    • 0037116179 scopus 로고    scopus 로고
    • Botulinum toxin A and the cutaneous nociception in humans: A prospective, double-blind, placebo-controlled, randomized study
    • Blersch W, Schulte-Mattler WJ, Przywara S, et al. Botulinum toxin A and the cutaneous nociception in humans: a prospective, double-blind, placebo-controlled, randomized study. J Neurol Sci 2002;205:59-63.
    • (2002) J Neurol Sci , vol.205 , pp. 59-63
    • Blersch, W.1    Schulte-Mattler, W.J.2    Przywara, S.3
  • 66
    • 0032839760 scopus 로고    scopus 로고
    • Botulinum toxin in the treatment of neurological disorders of the autonomic nervous system
    • Naumann M, Jost W, Toyka KV. Botulinum toxin in the treatment of neurological disorders of the autonomic nervous system. Arch Neurol 1999;56:914-16.
    • (1999) Arch Neurol , vol.56 , pp. 914-916
    • Naumann, M.1    Jost, W.2    Toyka, K.V.3
  • 67
    • 0035846569 scopus 로고    scopus 로고
    • Botulinum toxin type A in primary palmar hyperhidrosis. Randomized, single-blind, two-dase study
    • Saadia D, Voustianiouk A, Wang AK, et al. Botulinum toxin type A in primary palmar hyperhidrosis. Randomized, single-blind, two-dase study. Neurology 2001;57:2095-9.
    • (2001) Neurology , vol.57 , pp. 2095-2099
    • Saadia, D.1    Voustianiouk, A.2    Wang, A.K.3
  • 68
    • 0036885675 scopus 로고    scopus 로고
    • Effect of botulinum toxin type A on quality of life measures in patients with excessive axillary sweating: A randomized controlled trial
    • Naumann MK, Lowe NJ. Effect of botulinum toxin type A on quality of life measures in patients with excessive axillary sweating: a randomized controlled trial. Br J Dermatol 2002;147:1218-26.
    • (2002) Br J Dermatol , vol.147 , pp. 1218-1226
    • Naumann, M.K.1    Lowe, N.J.2
  • 69
    • 0035864927 scopus 로고    scopus 로고
    • Botulinum toxin A for axillary hyperhydrosis (excessive sweating)
    • Heckmann M, Ceballos-Baumann A, Plewig G, et al. Botulinum toxin A for axillary hyperhydrosis (excessive sweating). N Engl J Med 2001;344:488-93.
    • (2001) N Engl J Med , vol.344 , pp. 488-493
    • Heckmann, M.1    Ceballos-Baumann, A.2    Plewig, G.3
  • 70
    • 33845987422 scopus 로고    scopus 로고
    • Botulinum toxin, sweating, and body order
    • Heckmann M, Plewig G, Pause BM. Botulinum toxin, sweating, and body order. N Engl J Med 2002;347:620-1.
    • (2002) N Engl J Med , vol.347 , pp. 620-621
    • Heckmann, M.1    Plewig, G.2    Pause, B.M.3
  • 71
    • 0034126619 scopus 로고    scopus 로고
    • Injections of botulinum toxin A into the salivary glands improve sialorrhea in amyotrophic lateral sclerosis
    • Giess R, Naumann M, Werner E, et al. Injections of botulinum toxin A into the salivary glands improve sialorrhea in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 2000;69:121-3.
    • (2000) J Neurol Neurosurg Psychiatry , vol.69 , pp. 121-123
    • Giess, R.1    Naumann, M.2    Werner, E.3
  • 72
    • 0035059822 scopus 로고    scopus 로고
    • Treatment of sialorrhea with ultrasound guided botulinum toxin type A injection in patients with neurological disorders
    • Porta M, Gamba M, Bertacchi G, et al. Treatment of sialorrhea with ultrasound guided botulinum toxin type A injection in patients with neurological disorders. J Neurol Neurosurg Psychiatry 2001;70:538-40.
    • (2001) J Neurol Neurosurg Psychiatry , vol.70 , pp. 538-540
    • Porta, M.1    Gamba, M.2    Bertacchi, G.3
  • 73
    • 0345830743 scopus 로고    scopus 로고
    • A double-blind placebo-controlled trial of botulinum toxin B for sialorrhea in Parkinson's disease
    • Ondo WG, Hunter C, Moore W. A double-blind placebo-controlled trial of botulinum toxin B for sialorrhea in Parkinson's disease. Neurology 2004;62:37-40.
    • (2004) Neurology , vol.62 , pp. 37-40
    • Ondo, W.G.1    Hunter, C.2    Moore, W.3
  • 74
    • 0037061905 scopus 로고    scopus 로고
    • Botulinum toxin for cricopharyngeal dysfunction in Parkinson's disease
    • Restivo DA, Palmeri A, Marchese-Ragona R. Botulinum toxin for cricopharyngeal dysfunction in Parkinson's disease. N Engl J Med 2002;346:1174-5.
    • (2002) N Engl J Med , vol.346 , pp. 1174-1175
    • Restivo, D.A.1    Palmeri, A.2    Marchese-Ragona, R.3
  • 75
    • 0028922859 scopus 로고
    • Intrasphincteric botulinum toxin for the treatment of achalasia
    • Pasricha PJ, Ravich WJ, Hendrix T, et al. Intrasphincteric botulinum toxin for the treatment of achalasia. N Engl J Med 1995;322:774-8.
    • (1995) N Engl J Med , vol.322 , pp. 774-778
    • Pasricha, P.J.1    Ravich, W.J.2    Hendrix, T.3
  • 76
    • 0031612067 scopus 로고    scopus 로고
    • Use of botulinum toxin in the treatment of achalasia
    • Schiano TD, Parkman HP, Miller LS, et al. Use of botulinum toxin in the treatment of achalasia. Dig Dis 1998;16:14-22.
    • (1998) Dig Dis , vol.16 , pp. 14-22
    • Schiano, T.D.1    Parkman, H.P.2    Miller, L.S.3
  • 77
    • 0030949772 scopus 로고    scopus 로고
    • Untoward effects of esophageal botulinum toxin injection in the treatment of achalasia
    • Eaker EY, Gordon JM, Vogel SB. Untoward effects of esophageal botulinum toxin injection in the treatment of achalasia. Dig Dis Sci 1997;42:724-7.
    • (1997) Dig Dis Sci , vol.42 , pp. 724-727
    • Eaker, E.Y.1    Gordon, J.M.2    Vogel, S.B.3
  • 78
    • 0028023716 scopus 로고
    • Intrasphincteric injection of botulinum toxin for suspected sphincter of Oddi dysfunction
    • Pasricha PJ, Miskovsky EP, Kalloo AN. Intrasphincteric injection of botulinum toxin for suspected sphincter of Oddi dysfunction. Gut 1994;35:1319-21.
    • (1994) Gut , vol.35 , pp. 1319-1321
    • Pasricha, P.J.1    Miskovsky, E.P.2    Kalloo, A.N.3
  • 79
    • 10144219954 scopus 로고    scopus 로고
    • Initial North American experience with botulinum toxin a for treatment of anismus
    • Joo JS, Agachan F, Wollf B, et al. Initial North American experience with botulinum toxin a for treatment of anismus. Dis Colon Rectum 1996;39:1107-11.
    • (1996) Dis Colon Rectum , vol.39 , pp. 1107-1111
    • Joo, J.S.1    Agachan, F.2    Wollf, B.3
  • 80
    • 0030967764 scopus 로고    scopus 로고
    • Severe constipation in Parkinson's disease relieved by botulinum toxin
    • Albanese A, Maria G, Bentivoglio A, et al. Severe constipation in Parkinson's disease relieved by botulinum toxin. Mov Disord 1997;12:764-6.
    • (1997) Mov Disord , vol.12 , pp. 764-766
    • Albanese, A.1    Maria, G.2    Bentivoglio, A.3
  • 81
    • 0033536290 scopus 로고    scopus 로고
    • A comparison of injections of botulinum toxin and topical nitroglycerin ointment for the treatment of chronic anal fissure
    • Brisinda G, Maria G, Bentivoglio AR, et al. A comparison of injections of botulinum toxin and topical nitroglycerin ointment for the treatment of chronic anal fissure. N Engl J Med 1999;341:65-9.
    • (1999) N Engl J Med , vol.341 , pp. 65-69
    • Brisinda, G.1    Maria, G.2    Bentivoglio, A.R.3
  • 82
    • 0034594878 scopus 로고    scopus 로고
    • Treatment of neurogenic incontinence with botulinum toxin A
    • Schurch B, Schmid DM, Stohrer M. Treatment of neurogenic incontinence with botulinum toxin A. N Engl J Med 2000;342:665.
    • (2000) N Engl J Med , vol.342 , pp. 665
    • Schurch, B.1    Schmid, D.M.2    Stohrer, M.3
  • 83
    • 0032558305 scopus 로고    scopus 로고
    • Relief by botulinum toxin of voiding dysfunction due to prostatitis
    • Maria G, Destito A, Lacquanti S, et al. Relief by botulinum toxin of voiding dysfunction due to prostatitis. Lancet 1998;352:625.
    • (1998) Lancet , vol.352 , pp. 625
    • Maria, G.1    Destito, A.2    Lacquanti, S.3
  • 84
    • 0033755324 scopus 로고    scopus 로고
    • Perisphincteric injection of botulinum toxin type A. A treatment option for patients with chronic prostatic pain?
    • Zermann D, Ishigooka M, Schubert J, et al. Perisphincteric injection of botulinum toxin type A. A treatment option for patients with chronic prostatic pain? Eur Urol 2000;38:393-9.
    • (2000) Eur Urol , vol.38 , pp. 393-399
    • Zermann, D.1    Ishigooka, M.2    Schubert, J.3
  • 85
    • 0031015801 scopus 로고    scopus 로고
    • Treatment of vaginismus with botulinum toxin injections
    • Brin MF, Vapnek JM. Treatment of vaginismus with botulinum toxin injections. Lancet 1997;349:252-3.
    • (1997) Lancet , vol.349 , pp. 252-253
    • Brin, M.F.1    Vapnek, J.M.2
  • 86
    • 0028039081 scopus 로고
    • Treatment of acquired nystagmus with botulinum neurotoxin A
    • Repka MX, Savino PJ, Reinecke RD. Treatment of acquired nystagmus with botulinum neurotoxin A. Arch Ophthalmol 1994;112:1320-4.
    • (1994) Arch Ophthalmol , vol.112 , pp. 1320-1324
    • Repka, M.X.1    Savino, P.J.2    Reinecke, R.D.3
  • 87
    • 0035412940 scopus 로고    scopus 로고
    • Case of essential palatal tremor: Atypical features and remarkable benefit from botulinum toxin injections
    • Cho JW, Chu K, Jeon BS. Case of essential palatal tremor: atypical features and remarkable benefit from botulinum toxin injections. Mov Disord 2001;16:779-82.
    • (2001) Mov Disord , vol.16 , pp. 779-782
    • Cho, J.W.1    Chu, K.2    Jeon, B.S.3
  • 88
    • 0037176811 scopus 로고    scopus 로고
    • Not paralysis, but dystonia causes stridor in multiple system atrophy
    • Merlo IM, Occhini A, Pacchetti C, et al. Not paralysis, but dystonia causes stridor in multiple system atrophy. Neurology 2002;58:649-52.
    • (2002) Neurology , vol.58 , pp. 649-652
    • Merlo, I.M.1    Occhini, A.2    Pacchetti, C.3
  • 89
    • 0034641273 scopus 로고    scopus 로고
    • Botulinum toxin treatment of cocontractions after birth-related brachial plexus lesions
    • Rollnik JD, Hierner R, Schubert M, et al. Botulinum toxin treatment of cocontractions after birth-related brachial plexus lesions. Neurology 2000;55:112-14.
    • (2000) Neurology , vol.55 , pp. 112-114
    • Rollnik, J.D.1    Hierner, R.2    Schubert, M.3
  • 90
    • 0031086708 scopus 로고    scopus 로고
    • Counterparalysis for treatment of paralytic scoliosis with botulinum toxin type A
    • Nuzzo RM, Walsh S, Boucherit T, et al. Counterparalysis for treatment of paralytic scoliosis with botulinum toxin type A. Am J Orthop 1997;3:201-5.
    • (1997) Am J Orthop , vol.3 , pp. 201-205
    • Nuzzo, R.M.1    Walsh, S.2    Boucherit, T.3
  • 91
    • 0034929154 scopus 로고    scopus 로고
    • The effect of botulinum toxin injections to the calf muscles on freezing of gait in parkinsonism: A pilot study
    • Giladi N, Gurevich T, Shabtai H, et al. The effect of botulinum toxin injections to the calf muscles on freezing of gait in parkinsonism: a pilot study. J Neurol 2001;248:572-6.
    • (2001) J Neurol , vol.248 , pp. 572-576
    • Giladi, N.1    Gurevich, T.2    Shabtai, H.3
  • 92
    • 0030066710 scopus 로고    scopus 로고
    • Perioperative use of botulinum toxin for movement disorders-induced cervical spine disease
    • Adler CH, Zimmerman RS Lyons MK, et al. Perioperative use of botulinum toxin for movement disorders-induced cervical spine disease. Mov Disord 1996;11:79-81.
    • (1996) Mov Disord , vol.11 , pp. 79-81
    • Adler, C.H.1    Zimmerman, R.S.2    Lyons, M.K.3
  • 93
    • 0037154137 scopus 로고    scopus 로고
    • Botulinum toxin-induced paralysis of frontotemporal muscles improves seizure focus localization
    • Eisenchenk S, Gilmore RL, Uthman B, et al. Botulinum toxin-induced paralysis of frontotemporal muscles improves seizure focus localization. Neurology 2002;58:246-9.
    • (2002) Neurology , vol.58 , pp. 246-249
    • Eisenchenk, S.1    Gilmore, R.L.2    Uthman, B.3
  • 94
    • 0242467375 scopus 로고    scopus 로고
    • Botulinum toxin a (Botox® Cosmetic). A review of its use in the treatment of glabellar frown lines
    • Frampton JE, Easthope SE. Botulinum toxin a (Botox® Cosmetic). A review of its use in the treatment of glabellar frown lines. Am J Clin Dermatol 2003;4:709-25.
    • (2003) Am J Clin Dermatol , vol.4 , pp. 709-725
    • Frampton, J.E.1    Easthope, S.E.2
  • 95
    • 0032948693 scopus 로고    scopus 로고
    • Botulinum A exotoxin for the management of platysma bands
    • Matarasso A, Matarasso SL, Brandt FS, et al. Botulinum A exotoxin for the management of platysma bands. Plast Reconstr Surg 1999;103:645-52.
    • (1999) Plast Reconstr Surg , vol.103 , pp. 645-652
    • Matarasso, A.1    Matarasso, S.L.2    Brandt, F.S.3
  • 97
    • 0030066181 scopus 로고    scopus 로고
    • Treatment of facial synkinesis and facial asymmetry with botulinum toxin type A following facial nerve palsy
    • Armstrong MW, Mountain RE, Murray JA. Treatment of facial synkinesis and facial asymmetry with botulinum toxin type A following facial nerve palsy. Clin Otolaryngol 1996;21:15-20.
    • (1996) Clin Otolaryngol , vol.21 , pp. 15-20
    • Armstrong, M.W.1    Mountain, R.E.2    Murray, J.A.3
  • 98
    • 0031812134 scopus 로고    scopus 로고
    • Botulinum toxin treatment of synkinesia and hyperlacrimation after facial palsy
    • Boroojerdi B, Ferbert A, Schwarz M, et al. Botulinum toxin treatment of synkinesia and hyperlacrimation after facial palsy. J Neurol Neurosurg Psychiatry 1998;65:111-14.
    • (1998) J Neurol Neurosurg Psychiatry , vol.65 , pp. 111-114
    • Boroojerdi, B.1    Ferbert, A.2    Schwarz, M.3
  • 99
    • 0031448792 scopus 로고    scopus 로고
    • Cost-effectiveness of botulinum toxin type A injection in patients with spasticity following stroke: A German perspective
    • Wallesch C-W, Maes E, Lecomte P, et al. Cost-effectiveness of botulinum toxin type A injection in patients with spasticity following stroke: a German perspective. Eur J Neurol 1997;4(suppl 2):S53-7.
    • (1997) Eur J Neurol , vol.4 , Issue.2 SUPPL.
    • Wallesch, C.-W.1    Maes, E.2    Lecomte, P.3
  • 100
    • 0031795728 scopus 로고    scopus 로고
    • Effect of dystonia and botulinum toxin treatment on health-related quality of life
    • Gudex CM, Hawthorne MR, Butler AG, et al. Effect of dystonia and botulinum toxin treatment on health-related quality of life. Mov Disord 1998;13:941-6.
    • (1998) Mov Disord , vol.13 , pp. 941-946
    • Gudex, C.M.1    Hawthorne, M.R.2    Butler, A.G.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.